To: Lizzie Tudor who wrote (173554 ) 3/14/2003 11:45:38 AM From: hueyone Respond to of 186894 If I were offered the chance to exchange pay for options now, there would be no way I would take the bait because I don't think technology will recover intact from this onslaught. Edit: Please consider this post the operative post rather than my previous post, which I was unaware has posted. So it seems that we may finally beginning to reach a period where it could be construed that employees are forcing companies to expense stock options in some sense---by demanding cash instead of options. This lends support to the conclusion that this compensation expense was present all along, but the company was just able to temporarily mask it by not reporting the expense on the income statement. Although in your case, your decision to take cash is related to concern over a possible FASB decision that would require companies to expense stock options (which in turn you believe would depress stock prices), I suspect other employees may have come to the same conclusion to take cash instead of options even prior to the recent FASB announcement that increased the odds of stock options being expensed. The thing about not expensing stock options, imo, is that it is similar to a cortisone shot that temporarily makes you feel good and masks the real underlying performance of your body. Just as a person, despite cortisone shots, has to eventually deal with the underlying performance of their own body, companies heavily employing stock options and not expensing them eventually have to face the real, underlying economic performance of the firm. And the ability of the cortisone shots, or granting stock options without expensing them, to provide feel-good results eventually diminishes over time. Imo, companies like Intel will be better off by facing the music sooner rather than later, and expensing stock options on the income statement now. I think Intel still has an opportunity to make a rapid adjustment to expensing stock options on the income statement, and get back to running a solid, profitable company with a reasonable stock options program where options are expensed, before things get totally out of hand. Other companies, like SEBL for example, have already gone off the deep end imo. That company is a cortisone shot addict, and it is finding it harder and harder to get relief from the shots and harder and harder to get the company on track for legitimate economic performance. I am in agreement with Carl that going down the road of merrily increasing the grant rate to the inner circle (if indeed this is what is happening) is a very disturbing trend that can lead to bad results for everyone concerned, including the inner circle if they plan to hold any stock for the long term. It is short sighted management imo, something that I would not normally associate with Intel. On the other hand, Intel has pressure to write executive compensation packages that are competitive with the rest of the tech industry, which in its entirety, I now believe is based on an unsustainable business model---that of giving out lots of stock options and treating them as though they are no cost on the financial reports. I believe an early FASB decision to require companies to expense stock options could indeed be a blessing in disguise for Intel and all its shareholders---including outsiders, insiders, inner circle, employees---everyone concerned, and could get Intel back on track to managing for legitimate shareholder value sooner rather than later. Best regards, Huey